Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-261641 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 8, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
24,372
Total Value
$0.00
P&L
+inf% (+$424,316.52)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (right to buy) | Derivative | Jun 4, 2026 | Grant/Award | 24,372 | $0.00 | $0.00 | 24,372 | Direct | โ | View Details |